Is breast cancer HER2-positive curable?
- 1 people answered
Edit Tags
Tags are used to find the best answers
You might also be interested in
Study findings on a potential link between breast size and breast cancer have been mixed. Some studies have found having a larger breast size increases risk, while others have found no link between breast size and risk but few studies have suggested that breast size increases risk among thin women,....
In general, yes it is safe. But there are exceptions based on the conditions. A woman who is developing breast cancer might be excreting small amounts of fluids from the nipples. A woman who is lactating (to feed babies) is also ‘leaking’ fluids. Now, whenever a fluid is exchanged between two bod....
Two tests may be better than one. That’s the conclusion of researchers in a new study that looked at the reliability of both ultrasounds and mammograms. Where mammography is available, ultrasound should be seen as a supplemental test for women with dense breasts who do not meet high-risk criteria....
Credihealth is not a medical practitioner and does not provide medical advice. You should consult your doctor or with a healthcare professional before starting any diet, exercise, supplementation or medication program. Know More
लिहिलेले:Dr. Nitika Sharma - BDS
पुनरावलोकन:Dr. Rakesh Kumar - MBBS, MS
Kanishka Pandey
HER2 is a gene that creates HER2 proteins or receptors. These receptors help control growth and repair of breast cells. An overexpression of HER2 protein causes out-of-control reproduction of breast cells.
HER2-positive breast cancers are known to be more aggressive than HER2-negative breast cancers and are more likely to recur than HER2-negative breast cancer. The recurrence usually takes place within five years of treatment.
The good news is that recurrence is less likely these days than ever before. This is largely due to the latest targeted treatments. In fact, most people treated for early stage HER2-positive breast cancer don’t relapse. If your breast cancer is HR-positive, hormonal therapy may help reduce the risk of recurrence.
Your treatment plan will probably include a combination of therapies such as:
Targeted treatments (medicines like Herceptin, Kadcyla, Perjeta and Tykerb are used in this process) Once the treatment ends, you’ll still need periodic testing for signs of recurrence.